Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where G.W. van Oord is active.

Publication


Featured researches published by G.W. van Oord.


Journal of Viral Hepatitis | 2017

NK cells in self-limited HCV infection exhibit a more extensively differentiated, but not memory-like, repertoire

R. de Groen; Zwier M. A. Groothuismink; G.W. van Oord; N. A. Kootstra; H.L.A. Janssen; M. Prins; J. Schinkel; Andre Boonstra

Natural killer (NK) cells have long been thought of as a purely innate immune cell population, but increasing reports have described developmental and functional qualities of NK cells that are commonly associated with cells of the adaptive immune system. Of these features, the ability of NK cells to acquire functional qualities associated with immunological memory and continuous differentiation resulting in the formation of specific NK cell repertoires has recently been highlighted in viral infection settings. By making use of a unique cohort of monitored, at‐risk intravenous drug users in this study, we were able to dissect the phenotypic and functional parameters associated with NK cell differentiation and NK cell memory in patients 3 years after acute HCV infection and either the subsequent self‐clearance or progression to chronicity. We observed increased expression of cytolytic mediators and markers CD56bright and NKp46+ of NK cells in patients with chronic, but not self‐limited HCV infection. Patients with a self‐limited infection expressed higher levels of differentiation‐associated markers CD57 and KIRs, and lower levels of NKG2A. A more extensively differentiated NK cell phenotype is associated with self‐clearance in HCV patients, while the NK cells of chronic patients exhibited more naïve and effector NK cell phenotypic and functional characteristics. The identification of these distinct NK cell repertoires may shed light on the role NK cells play in determining the outcome of acute HCV infections, and the underlying immunological defects that lead to chronicity.


Clinical Microbiology and Infection | 2016

Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen–positive chronic hepatitis B patients

M.J. van Campenhout; W.P. Brouwer; G.W. van Oord; Q. Xie; Q. Zhang; Ningping Zhang; S. Guo; Fehmi Tabak; Anca Streinu-Cercel; Ji-Yao Wang; Suzan D. Pas; Milan J. Sonneveld; R.J. de Knegt; Andre Boonstra; Bettina E. Hansen; H.L.A. Janssen


Journal of Hepatology | 2017

Characterization of the intrahepatic immune response of virally-suppressed chronic hepatitis B patients to treatment with the oral TLR7 agonist GS-9620

Lauke L. Boeijen; G.W. van Oord; Jun Hou; M.J. van Campenhout; M. van der Heide-Mulder; A. Gaggar; L. Li; Simon P. Fletcher; R.J. de Knegt; A. Boonstra


Journal of Hepatology | 2017

Pegylated interferon alpha treatment rapidly clears Hepatitis E Virus infections in humanized mice

M.D. van de Garde; S.D. Pas; G.W. van Oord; Lucio Gama; Youkyung Choi; R.A. de Man; A. Boonstra; Thomas Vanwolleghem


Journal of Hepatology | 2017

MAIT cell frequency and function in blood and liver of hepatitis C virus mono- and hepatitis C virus/human immunodeficiency virus co-infected patients with mild versus advanced fibrosis

B. Beudeker; G.W. van Oord; Joop E. Arends; J.S. zur Wiesch; R.J. de Knegt; Annelies Verbon; A. Boonstra; Mark A.A. Claassen


Journal of Hepatology | 2017

Hepatocyte single cell sequencing to identify transcript modulation by hepatitis C virus

J.D. Debes; C. Reilly; G.W. van Oord; P.R. Bohjanen; Thomas Vanwolleghem; A. Boonstra


Journal of Hepatology | 2017

Clinical evaluation of hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B

M.J. van Campenhout; G.W. van Oord; V. Rijckborst; W.P. Brouwer; Peter Ferenci; Fehmi Tabak; Meral Akdogan; B. Pinarbasi; Krzysztof Simon; M. Raptopoulou-Gigi; R.J. de Knegt; A. Boonstra; H.L.A. Janssen; Bettina E. Hansen


Journal of Hepatology | 2017

FRI-290 – Pegylated interferon alpha treatment rapidly clears Hepatitis E Virus infections in humanized mice

M.D. van de Garde; S.D. Pas; G.W. van Oord; Lucio Gama; Youkyung Choi; R.A. de Man; A. Boonstra; Thomas Vanwolleghem


Journal of Hepatology | 2016

Similar Frequencies, Phenotype and Activation Status of Intrahepatic NK Cells in Chronic HBV Patients after Long-Term Treatment with Tenofovir Disoproxil Fumarate (TDF)

Lauke L. Boeijen; M.J. van Campenhout; Eric T. Tjwa; Roeland Zoutendijk; G.W. van Oord; R.J. de Knegt; H.L.A. Janssen; Andrea M. Woltman; A. Boonstra


Journal of Hepatology | 2016

Do Mucosal-Associated Invariant T (Mait) Cells Impact Fibrosis in HCV and HIV/HCV Co-Infected Patients?

B. Beudeker; G.W. van Oord; M. Van der Heide; R.J. de Knegt; Annelies Verbon; A. Boonstra; Mark A.A. Claassen

Collaboration


Dive into the G.W. van Oord's collaboration.

Top Co-Authors

Avatar

R.J. de Knegt

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

A. Boonstra

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

H.L.A. Janssen

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Andre Boonstra

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

M.J. van Campenhout

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Bettina E. Hansen

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Jun Hou

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

R. de Groen

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

W.P. Brouwer

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge